Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review

Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review

Abstract Background Inflammatory Bowel Disease (IBD) affects reproductive-aged women. Active disease can lead to decreased fertility. Although the vast majority of international guidelines recommend for the continuation of anti-TNF-α during pregnancy, recent studies have raised concerns about the sa...

Full description

Bibliographic Details
Main Authors: Wei Huang, Xinxing Zhang, Li Zhang, Xiaosong Dai, Heping Chen, Qin Xie
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Pregnancy and Childbirth
Subjects:
Inflammatory bowel disease
Tumor necrosis factor
Pregnancy
Biologic treatment
Adverse pregnancy outcomes
Online Access:https://doi.org/10.1186/s12884-024-06443-w

Internet

https://doi.org/10.1186/s12884-024-06443-w

Similar Items